169 related articles for article (PubMed ID: 2647576)
1. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.
Adler G; Reinshagen M; Koop I; Göke B; Schafmayer A; Rovati LC; Arnold R
Gastroenterology; 1989 Apr; 96(4):1158-64. PubMed ID: 2647576
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Niederau C; Liddle RA; Williams JA; Grendell JH
Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
[TBL] [Abstract][Full Text] [Related]
3. Effect of atropine on feedback regulation of pancreatic secretion in rats.
Weidenbach H; Printz H; Göke B; Koop I; Schafmayer A; Adler G
Res Exp Med (Berl); 1989; 189(3):221-8. PubMed ID: 2473503
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans.
Adler G; Beglinger C; Braun U; Reinshagen M; Koop I; Schafmayer A; Rovati L; Arnold R
Gastroenterology; 1991 Feb; 100(2):537-43. PubMed ID: 1702077
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of pancreatic secretion in man by a protease inhibitor (camostate).
Adler G; Müllenhoff A; Koop I; Bozkurt T; Göke B; Beglinger C; Arnold R
Eur J Clin Invest; 1988 Feb; 18(1):98-104. PubMed ID: 3130267
[TBL] [Abstract][Full Text] [Related]
6. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
Gabryelewicz A; Kulesza E; Konturek SJ
Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
[TBL] [Abstract][Full Text] [Related]
7. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effect of single and repeated administrations of a protease inhibitor (Camostate) on pancreatic secretion in man.
Adler G; Müllenhoff A; Bozkurt T; Göke B; Koop I; Arnold R
Scand J Gastroenterol; 1988 Mar; 23(2):158-62. PubMed ID: 3363288
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
[TBL] [Abstract][Full Text] [Related]
10. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas.
Wisner JR; McLaughlin RE; Rich KA; Ozawa S; Renner IG
Gastroenterology; 1988 Jan; 94(1):109-13. PubMed ID: 3335282
[TBL] [Abstract][Full Text] [Related]
11. Feedback regulation of exocrine pancreatic secretion in dogs.
Schafmayer A; Nustede R; Köhler H
Pancreas; 1993 Sep; 8(5):627-31. PubMed ID: 8302801
[TBL] [Abstract][Full Text] [Related]
12. Negative feedback regulation of pancreatic exocrine secretion in guinea pigs.
Kim CD; Lee KY; Chang TM; Chey WY
Pancreas; 1995 Mar; 10(2):173-9. PubMed ID: 7716142
[TBL] [Abstract][Full Text] [Related]
13. Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man.
Beglinger C; Hildebrand P; Adler G; Werth B; Luo H; Delco F; Gyr K
Eur J Clin Invest; 1992 Dec; 22(12):827-34. PubMed ID: 1282465
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function.
Niederau C; Lüthen R; Niederau M; Strohmeyer G; Ferrell LD; Grendell JH
Digestion; 1990; 46 Suppl 2():217-25. PubMed ID: 2262055
[TBL] [Abstract][Full Text] [Related]
15. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
[TBL] [Abstract][Full Text] [Related]
17. Role of intraduodenal proteases in plasma cholecystokinin and pancreaticobiliary responses to protein and amino acids.
Thimister PW; Hopman WP; Sloots CE; Rosenbusch G; Willems HL; Trijbels FJ; Jansen JB
Gastroenterology; 1996 Feb; 110(2):567-75. PubMed ID: 8566605
[TBL] [Abstract][Full Text] [Related]
18. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
[TBL] [Abstract][Full Text] [Related]
19. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
Cancer Lett; 1991 Dec; 60(3):205-11. PubMed ID: 1756510
[TBL] [Abstract][Full Text] [Related]
20. Adaptation of the human pancreas to inhibition of luminal proteolytic activity.
Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW
Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
